top of page


10 Calls to Action for improving care for adult patients living with pulmonary hypertension
The Pulmonary Hypertension Global Patient Survey (PHGPS), the largest survey to date to explore the perspectives of patients with PH at...

PHA Canada
Jul 17, 20252 min read


Items that make living with pulmonary hypertension easier
Here are a few things that the Canadian PHriends Facebook group members found make their lives easier. Around the house Air conditioning...

PHA Canada
Jul 17, 20251 min read
Hymecromone clinical trial is cautiously positive
A very small (16 patients) phase 2a clinical trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD) looked...
Robyn Kalda
Jul 7, 20251 min read
Meth-associated PAH care gaps: closing the divide
We know methamphetamine use is associated with pulmonary arterial hypertension (PAH), but this population's care needs haven't been...
Robyn Kalda
Jun 23, 20251 min read


Canada Disability Benefit applications open this week
Applications for the Canada Disability Benefit (CDB) open this week. If you're eligible for the Disability Tax Credit and you (and your...
PHA Canada
Jun 17, 20251 min read


Honouring Andrew Barfoot: A Day of Community, Kindness, and Legacy
On a beautiful June day filled with sunshine and warmth, our community gathered for a special fundraiser in honour of Andrew Barfoot....
Sherry Foster
Jun 10, 20252 min read
IV selexipag can be used as a bridging therapy
Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily...
PHA Canada
Jun 9, 20251 min read


Quick Facts: What is Yutrepia?
What it is Yutrepia is a new drug: an inhaled form of treprostinil, a prostacyclin analogue. It was just approved by the Food and Drug...
PHA Canada
Jun 3, 20251 min read


From Diagnosis to Advocacy: Heather’s PAH Journey
I was diagnosed with pulmonary arterial hypertension (PAH) in June 2024. In hindsight, knowing the symptoms as I do now, I might have had...
PHA Canada
May 29, 20252 min read


Quick facts: Why was the ZENITH sotatercept study stopped?
The ZENITH study looked at some of the sickest pulmonary arterial hypertension (PAH) patients—those labelled as functional class 3...
PHA Canada
May 28, 20252 min read


There's no health without mental health
"A person's mental health significantly influences how they experience pain and suffering associated with chronic disease. It's essential...
PHA Canada
May 27, 20252 min read


What's the Canada Disability Benefit?
We asked Liss Cairns, Program Manager at Plan Institute, some questions about the Disability Tax Credit and the new Canada Disability...
PHA Canada
May 27, 20251 min read


Speaking for Candice: A Mother’s Plea for PAH Patients
Hello. My name is Denise Rumbolt and I’d like to tell you about my daughter, Candice. Like any mother, I’ll tell you she’s beautiful,...
PHA Canada
May 26, 20252 min read
Prostacyclin analogues for CTEPH?
This systemic review summarized the data from six studies that examined whether prostacyclin analogues are safe and useful when used to...
PHA Canada
May 26, 20251 min read


Rare But Not Alone: What Canada’s New Drug Strategy Means for People with Pulmonary Arterial Hypertension
Living with a rare disease can feel like walking an unmarked path—isolated, uncertain, and overlooked. For those with pulmonary arterial...
PHA Canada
May 13, 20252 min read
Some PAH patients on sotatercept can stop taking prostacyclin analogues
In a small study of 34 pulmonary arterial hypertension (PAH) patients taking triple therapy plus sotatercept, some were able to stop...
PHA Canada
May 12, 20251 min read


Sotatercept Is Not Just Another Medication
My name is Cindy Hayman, and I have been living with Pulmonary Arterial Hypertension (PAH) for the past seven years. I am classified as a...
PHA Canada
May 8, 20252 min read
PHA Canada Marks World Pulmonary Hypertension Day with National Advocacy Events Calling for Timely Access to Treatment
On May 5, World Pulmonary Hypertension Day , the Pulmonary Hypertension Association of Canada (PHA Canada) is calling for urgent action...
PHA Canada
May 5, 20252 min read


Left-Sided Heart Disease & Pulmonary Hypertension
I was diagnosed with Pulmonary Hypertension in 2019. After tests & procedures, it was determined I likely had group 2 and 3 PH. Group 2...
Dawn Clarke - patient
May 1, 20253 min read
Poverty and isolation are associated with worse pulmonary hypertension outcomes
A 2024 study looked at the association between socioeconomic disadvantage and pulmonary hypertension. In one New York hospital system,...
PHA Canada
Apr 28, 20251 min read
bottom of page
